Shen Jing, Reis Julia, Morrison David C, Papasian Christopher, Raghavakaimal Sreekumar, Kolbert Christopher, Qureshi Asaf A, Vogel Stefanie N, Qureshi Nilofer
Department of Basic Medical Science, School of Medicine, and Shock/Trauma Research Center, University of Missouri, Kansas City, MO 64108, USA.
Shock. 2006 May;25(5):472-84. doi: 10.1097/01.shk.0000209554.46704.64.
Lipopolysaccharide (LPS) is a major structural component of all Gram-negative organisms and has been implicated in Gram-negative sepsis and septic shock. In the present study, Affymetrix microarray analysis of RNA derived from murine macrophages treated with LPS in the absence or presence of the proteasome inhibitor lactacystin revealed that the vast majority of genes regulated by LPS is under control of the proteasome. Analysis of the data has revealed that the products of these genes participate in 14 distinct signaling pathways. This represents a novel approach to the identification of signaling pathways that are both toll-like receptor 4- and proteasome-dependent and may lead to the development of new drug targets in Gram-negative sepsis and septic shock.
脂多糖(LPS)是所有革兰氏阴性菌的主要结构成分,与革兰氏阴性菌败血症和感染性休克有关。在本研究中,对在不存在或存在蛋白酶体抑制剂乳胞素的情况下用LPS处理的小鼠巨噬细胞来源的RNA进行的Affymetrix微阵列分析表明,绝大多数受LPS调节的基因受蛋白酶体控制。数据分析显示,这些基因的产物参与14条不同的信号通路。这代表了一种鉴定依赖Toll样受体4和蛋白酶体的信号通路的新方法,可能会导致革兰氏阴性菌败血症和感染性休克新药靶点的开发。